Research Article
Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients
Figure 2
(a) Average length of stay in hospital for COVID-19 patients (favipiravir-treated and not treated with favipiravir) (n = 103, n = 62, respectively). (b) Average length of stay in ICU for COVID-19 patients (favipiravir-treated and not treated with favipiravir) (n = 21, n = 16, respectively) ().
(a) |
(b) |